Elnora AI
Tallinn
About Elnora AI
Elnora AI revolutionizes drug discovery by leveraging AI and the academic research community. The company focuses on developing antiviral drugs by targeting host cells instead of viruses directly, which helps in providing resistance to various viral infections. Elnora AI's platform brings researchers together to make drug discovery faster and more cost-effective. The company analyzes vast amounts of scientific data to identify and develop new virus-targeting drugs using AI-powered methods.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: Less than $1M
- Last round: Convertible Note (Jan 2025)
- Website: elnora.ai
- Phone: +372 5196 5196
Industries & Categories
Artificial Intelligence (AI), Biotechnology, Database
Social Profiles
Canonical: https://fsome.com/organization/elnora-ai-2238552 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.